Operating Income (Loss) in USD of NEUROCRINE BIOSCIENCES INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NEUROCRINE BIOSCIENCES INC quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • NEUROCRINE BIOSCIENCES INC Operating Income (Loss) for the quarter ending 30 Sep 2025 was $239M, a 30% increase year-over-year.
  • NEUROCRINE BIOSCIENCES INC Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $550M, a 4.94% decline year-over-year.
  • NEUROCRINE BIOSCIENCES INC annual Operating Income (Loss) for 2024 was $571M, a 127% increase from 2023.
  • NEUROCRINE BIOSCIENCES INC annual Operating Income (Loss) for 2023 was $251M, a 0.76% increase from 2022.
  • NEUROCRINE BIOSCIENCES INC annual Operating Income (Loss) for 2022 was $249M, a 143% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

NEUROCRINE BIOSCIENCES INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $550M $239M +$55.2M +30% 01 Jul 2025 30 Sep 2025 10-Q 28 Oct 2025
Q2 2025 $495M $146M +$200K +0.14% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025
Q1 2025 $495M $23.6M -$75.7M -76.2% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025
Q4 2024 $571M $142M -$8.3M -5.52% 01 Oct 2024 31 Dec 2024 10-K 10 Feb 2025
Q3 2024 $579M $184M +$42.6M +30.2% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2025
Q2 2024 $536M $145M +$71.8M +97.6% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025
Q1 2024 $464M $99.3M +$214M 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025
Q4 2023 $251M $150M +$46.9M +45.4% 01 Oct 2023 31 Dec 2023 10-K 10 Feb 2025
Q3 2023 $204M $141M +$53.4M +60.8% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024
Q2 2023 $151M $73.6M +$18.9M +34.6% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024
Q1 2023 $132M -$114M -$117M -3784% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024
Q4 2022 $249M $103M +$140M 01 Oct 2022 31 Dec 2022 10-K 10 Feb 2025
Q3 2022 $109M $87.8M +$43.3M +97.3% 01 Jul 2022 30 Sep 2022 10-Q 31 Oct 2023
Q2 2022 $66M $54.7M -$8.1M -12.9% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023
Q1 2022 $74.1M $3.1M -$28.4M -90.2% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 $103M -$36.3M -$108M -151% 01 Oct 2021 31 Dec 2021 10-K 09 Feb 2024
Q3 2021 $211M $44.5M +$88.8M 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 $122M $62.8M -$13.8M -18% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $136M $31.5M -$27.4M -46.5% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $163M $71.8M +$23M +47.1% 01 Oct 2020 31 Dec 2020 10-K 09 Feb 2023
Q3 2020 $140M -$44.3M -$134M -149% 01 Jul 2020 30 Sep 2020 10-Q 01 Nov 2021
Q2 2020 $274M $76.6M +$42.2M +123% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 $232M $58.9M +$160M 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 $72.3M $48.8M +$27M +124% 01 Oct 2019 31 Dec 2019 10-K 11 Feb 2022
Q3 2019 $45.3M $90.1M +$35.8M +65.9% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $9.5M $34.4M +$36.3M 01 Apr 2019 30 Jun 2019 10-Q 03 Aug 2020
Q1 2019 -$26.8M -$101M -$63.6M -170% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 $36.8M $21.8M +$9.94M +84% 01 Oct 2018 31 Dec 2018 10-K 05 Feb 2021
Q3 2018 $26.9M $54.3M +$60.3M 01 Jul 2018 30 Sep 2018 10-Q 04 Nov 2019
Q2 2018 -$33.5M -$1.85M +$55.4M +96.8% 01 Apr 2018 30 Jun 2018 10-Q 29 Jul 2019
Q1 2018 -$88.9M -$37.4M +$42.5M +53.2% 01 Jan 2018 31 Mar 2018 10-Q 29 Apr 2019
Q4 2017 -$131M $11.8M +$58.1M 01 Oct 2017 31 Dec 2017 10-K 07 Feb 2020
Q3 2017 -$189M -$6M +$32.4M +84.4% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018
Q2 2017 -$222M -$57.3M -$15.4M -36.9% 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018
Q1 2017 -$206M -$79.9M -$59.1M -283% 01 Jan 2017 31 Mar 2017 10-Q 30 Apr 2018
Q4 2016 -$147M -$46.3M -$15.5M -50.4% 01 Oct 2016 31 Dec 2016 10-K 08 Feb 2019
Q3 2016 -$132M -$38.4M -$2.59M -7.23% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017
Q2 2016 -$129M -$41.8M -$16.5M -65.2% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017
Q1 2016 -$113M -$20.9M -$18.6M -812% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q4 2015 -$94.2M -$30.7M -$10.3M -50.2% 01 Oct 2015 31 Dec 2015 10-K 13 Feb 2018
Q3 2015 -$83.9M -$35.8M -$19M -113% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016
Q2 2015 -$64.9M -$25.3M -$11M -76.3% 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016
Q1 2015 -$54M -$2.29M +$10.4M +82% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016
Q4 2014 -$64.4M -$20.5M -$8.94M -77.5% 01 Oct 2014 31 Dec 2014 10-K 14 Feb 2017
Q3 2014 -$55.5M -$16.9M -$4.85M -40.4% 01 Jul 2014 30 Sep 2014 10-Q 29 Oct 2015
Q2 2014 -$50.6M -$14.4M -$1.19M -9.07% 01 Apr 2014 30 Jun 2014 10-Q 29 Jul 2015
Q1 2014 -$49.4M -$12.7M +$250K +1.93% 01 Jan 2014 31 Mar 2014 10-Q 30 Apr 2015
Q4 2013 -$49.7M -$11.5M -$20.1M -234% 01 Oct 2013 31 Dec 2013 10-K 11 Feb 2016
Q3 2013 -$29.6M -$12M -$8.04M -203% 01 Jul 2013 30 Sep 2013 10-Q 04 Nov 2014
Q2 2013 -$21.5M -$13.2M -$11.8M -854% 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014
Q1 2013 -$9.74M -$13M -$11.2M -624% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014
Q4 2012 $1.45M $8.58M +$8.14M +1820% 01 Oct 2012 31 Dec 2012 10-K 09 Feb 2015
Q3 2012 -$6.69M -$3.96M -$34.4M -113% 01 Jul 2012 30 Sep 2012 10-Q 29 Oct 2013
Q2 2012 $27.7M -$1.38M -$2.48M -226% 01 Apr 2012 30 Jun 2012 10-Q 26 Jul 2013
Q1 2012 $30.2M -$1.79M -$3.73M -192% 01 Jan 2012 31 Mar 2012 10-Q 02 May 2013
Q4 2011 $33.9M $447K 01 Oct 2011 31 Dec 2011 10-K 11 Feb 2014
Q3 2011 $30.4M +$28M +1134% 01 Jul 2011 30 Sep 2011 10-Q 31 Oct 2012
Q2 2011 $1.1M +$6.99M 01 Apr 2011 30 Jun 2011 10-Q 31 Jul 2012
Q1 2011 $1.94M 01 Jan 2011 31 Mar 2011 10-Q 02 May 2012
Q3 2010 $2.47M 01 Jul 2010 30 Sep 2010 10-Q 31 Oct 2011
Q2 2010 -$5.89M 01 Apr 2010 30 Jun 2010 10-Q 29 Jul 2011

NEUROCRINE BIOSCIENCES INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $571M +$320M +127% 01 Jan 2024 31 Dec 2024 10-K 10 Feb 2025
2023 $251M +$1.9M +0.76% 01 Jan 2023 31 Dec 2023 10-K 10 Feb 2025
2022 $249M +$147M +143% 01 Jan 2022 31 Dec 2022 10-K 10 Feb 2025
2021 $103M -$60.5M -37.1% 01 Jan 2021 31 Dec 2021 10-K 09 Feb 2024
2020 $163M +$90.7M +125% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023
2019 $72.3M +$35.5M +96.5% 01 Jan 2019 31 Dec 2019 10-K 11 Feb 2022
2018 $36.8M +$168M 01 Jan 2018 31 Dec 2018 10-K 05 Feb 2021
2017 -$131M +$16M +10.9% 01 Jan 2017 31 Dec 2017 10-K 07 Feb 2020
2016 -$147M -$53.2M -56.4% 01 Jan 2016 31 Dec 2016 10-K 08 Feb 2019
2015 -$94.2M -$29.8M -46.3% 01 Jan 2015 31 Dec 2015 10-K 13 Feb 2018
2014 -$64.4M -$14.7M -29.7% 01 Jan 2014 31 Dec 2014 10-K 14 Feb 2017
2013 -$49.7M -$51.1M -3531% 01 Jan 2013 31 Dec 2013 10-K 11 Feb 2016
2012 $1.45M -$32.5M -95.7% 01 Jan 2012 31 Dec 2012 10-K 09 Feb 2015
2011 $33.9M +$47.6M 01 Jan 2011 31 Dec 2011 10-K 11 Feb 2014
2010 -$13.7M 01 Jan 2010 31 Dec 2010 10-K 08 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.